Neurontin, a product of Pfizer Inc. was approved by the FDA in 1994 for treatment of partial seizures usually associated with epilepsy. It was later approved for pain management associated with postherpetic neuralgia as a result of shingles.
Side-Effects of Neurontin
Most side-effects of Neurontin are relatively mild and fairly common. Some examples of common side-effects are headache, dizziness, sleepiness, and nausea. Unfortunately, Neurontin has also been linked to other, more dangerous side-effects including:
- Memory Loss
- Viral Infections
- Vomiting and Diarrhea
- Mood Swings
- Suicidal Tendencies and other Psychological Effects (children have been shown to be more susceptible to psychological effects of Neurontin)
Pfizer Markets Neurontin for Off-Label Use
Shortly after Neurontin appeared on the market in 1994 the drugs manufacturer, Pfizer Inc. began intensive marketing of the drug for off-label purposes. It has been shown that Pfizer was marketing the drug for purposes unapproved by the Food and Drug Administration. Such purposes included bipolar disorder, attention deficit disorder, migraines and drug and alcohol withdrawal.
Pharmaceutical Litigation Attorneys at Bailey & Galyen have extensive experience in cases involving injury or wrongful death associated with prescription drugs. Contact us o set an appointment with an attorney to discuss your case.